Association Between Nanobacteria and Periodontal Disease
2003; Lippincott Williams & Wilkins; Volume: 108; Issue: 8 Linguagem: Inglês
10.1161/01.cir.0000086781.16968.2d
ISSN1524-4539
AutoresNeva Çiftçioğlu, D. S. McKay, E. Olavi Kajander,
Tópico(s)Endodontics and Root Canal Treatments
ResumoHomeCirculationVol. 108, No. 8Association Between Nanobacteria and Periodontal Disease Free AccessLetterPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessLetterPDF/EPUBAssociation Between Nanobacteria and Periodontal Disease Neva Çiftçioğlu David S. McKay E. Olavi Kajander Neva ÇiftçioğluNeva Çiftçioğlu Universities Space Research Association, NASA/Johnson Space Center, Houston, Tex, David S. McKayDavid S. McKay NASA/Johnson Space Center, Houston, Tex E. Olavi KajanderE. Olavi Kajander Department of Biochemistry, University of Kuopio, Fin-70211 Finland Originally published26 Aug 2003https://doi.org/10.1161/01.CIR.0000086781.16968.2DCirculation. 2003;108:e58–e59To the Editor:Hung et al1 recently reported that the association between periodontal disease and incident tooth loss and peripheral arterial disease (PAD) is probably mediated via the oral infection-inflammation pathway. Discussions on the same hypothesis have been continuing for many decades. But so far, no clear cause-and-effect relationship has been found. Part of the link between these two diseases may be discovered through novel investigations of the opportunistic, infectious bacteria that colonize the mouth, form biofilm, cause periodontal disease, and activate white blood cells to release proinflammatory mediators that may contribute to heart disease and stroke. There are >300 species of known bacteria forming populations of several hundred billion in the human oral cavity. The number of bacteria reaches a thousand billion when the mouth is not sufficiently cleaned.Coronary atherosclerosis (CA) has been suggested to be an inflammatory disease in which chronic dental infections may trigger pathogenic mechanisms in the walls of arteries. Vascular calcification increases the severity of CA and is one of the biggest problems in this disease. Definitive mechanisms causing vascular calcification are unknown. Because nanobacteria (NB) form surface calcifications at physiological levels of calcium and phosphate, they have been hypothesized to mediate tissue calcifications.2 These self-replicating, biofilm-forming, tetracycline-sensitive3 agents remain controversial because of apatite coat and resistance to extraction of their components by conventional methods.2 Our preliminary work with 18 dental pulp stones, selected only by severity of the stone formation, indicated the presence of NB antigens in the demineralized stones.4 Furthermore, we found a high incidence of kidney stones and gallstones in the patient group and in their parents.4 A research group from the Mayo Clinic in Rochester, Minn, has recently detected NB in calcified carotid arteries, aortic aneurysms, and cardiac valves by using electron microscopy and immunohistochemical staining techniques.5Should the link between oral disease and heart disease be firmly established, future studies should focus on identifying the specific biological factors involved and transferring this knowledge to prevent disease. The model for modern infectious disease research is to systematically consider a variety of potential infectious agents. Because NB can be identified by using culture, monoclonal antibodies, and electron microscopy techniques, and because they were detected in both dental pulp stones and CA, NB should be considered a potential causative agent to be screened in related diseases. We propose that NB may provide a potential bridge between periodontal diseases and PAD. This relationship is worthy of further study.1 Hung HC, Willett W, Merchant A, et al. Oral health and peripheral arterial disease. Circulation. 2003; 107: 1152–1157.LinkGoogle Scholar2 Kajander EO, Çiftçioğlu N. Nanobacteria: an alternative mechanism for pathogenic intra- and extracellular calcification and stone formation. Proc Natl Acad Sci U S A. 1998; 95: 8274–8279.CrossrefMedlineGoogle Scholar3 Çiftçioğlu N, Miller-Hjelle MA, Hjelle JT, et al. Inhibition of nanobacteria by antimicrobial drugs as measured by modified microdilution method. Antimicrob Agents Chemother. 2002; 46: 2077–2086.CrossrefMedlineGoogle Scholar4 Çiftçioğlu N, Çiftçioğlu V, Vali H, et al. Sedimentary rocks in our mouth: dental pulp stones made by Nanobacteria. In: Hoover RB, ed. Instruments, Methods, and Missions for Astrobiology. International Society for Optical Engineering. Proceedings of SPIE. 1998; 3441: 130–135.Google Scholar5 Rasmussen TE, Kirkland BL, Charlesworth J, et al. Electron microscope and immunological evidence of nanobacterial-like structures in calcified carotid arteries, aortic aneurysms and cardiac valves. J Am Coll Cardiol Abstract Publications Book. 2002;206A.Google ScholarcirculationahaCirculationCirculationCirculation0009-73221524-4539Lippincott Williams & WilkinsResponseHung Hsin-Chia, , Willett Walter, , Merchant Anwar, , Rosner Bernard A., , Ascherio Alberto, , and Joshipura Kaumudi J., 26082003We have proposed several potential explanations for the association between oral health and cardiovascular disease, and the activation or release of inflammatory mediators caused by bacteria is one.1–3 However, different measures of oral health, such as the number of remaining teeth, recent tooth loss, and periodontal disease that could reflect different pathways, showed different relationships with 3 the following atherosclerotic diseases: coronary heart disease, stroke, and peripheral arterial disease.1–3 This suggests that the association between oral health and cardiovascular diseases is complex.Antibiotics consistently reduced atherosclerotic vascular disease in four of five small clinical trials with low power, but larger trials testing the relationship between antibiotics and coronary heart disease gave equivocal results.4 A possible explanation consistent with these data may be that infection plays a larger role in atherosclerotic disease such as peripheral arterial disease compared with coronary heart disease, where other factors such as plaque stability may be more important. We therefore agree with Çiftçioğlu et al that >300 species of known bacteria with populations of several hundred billion in the human oral cavity, and even higher among periodontal disease patients, could possibly contribute to development of peripheral arterial disease in particular. Nanobacteria (NB) might be associated with tissue calcifications and hence could increase risk of coronary atherosclerosis. Although NB has been detected in calcified carotid arteries, the evidence to support a causal association with cardiovascular diseases is still limited. Moreover, there is no evidence that NB is associated with periodontal diseases, even though NB has been identified in tooth pulp stone and saliva, as well as in dental plaque.5We agree that it is important to evaluate specific biological factors that could contribute to these associations, including common genetic factors, microbial factors, cytokines, and other inflammatory mediators. Microorganisms, including bacterial species known to be associated with periodontal disease, are definitely worthy of further study in this context. The qualitative or quantitative differences of NB in specimens from the oral cavity (ie, saliva, dental plaque, or gingival crevicular fluid) between subjects with and without periodontal disease must be documented while considering the role of NB in the relationship between periodontal disease and peripheral artery disease, and we agree that this is worthy of further study. Previous Back to top Next FiguresReferencesRelatedDetailsCited By Xu X, Lai Y, Zhou W, Wu L and Hua Z (2019) Quantification of a cell culture contaminant using 16S rDNA, Biotechnology and Applied Biochemistry, 10.1002/bab.1792, 66:5, (815-822), Online publication date: 1-Sep-2019. Yaghobee S, Bayani M, Samiei N and Jahedmanesh N (2015) What are the nanobacteria?, Biotechnology & Biotechnological Equipment, 10.1080/13102818.2015.1052761, 29:5, (826-833), Online publication date: 3-Sep-2015. Wu C, Young L, Young D, Martel J, Young J and Chin W (2013) Bions: A Family of Biomimetic Mineralo-Organic Complexes Derived from Biological Fluids, PLoS ONE, 10.1371/journal.pone.0075501, 8:9, (e75501) Kim T, Kim H and Myung S (2011) Detection of Nanobacteria in Patients with Chronic Prostatitis and Vaginitis by Reverse Transcriptase Polymerase Chain Reaction, Korean Journal of Urology, 10.4111/kju.2011.52.3.194, 52:3, (194), . Çiftçioğlu N and McKay D (2010) Pathological Calcification and Replicating Calcifying-Nanoparticles: General Approach and Correlation, Pediatric Research, 10.1203/PDR.0b013e3181d476ce, 67:5, (490-499), Online publication date: 1-May-2010. Schwartz M, Hunter L, Huebner M, Lieske J and Miller V (2009) Characterization of biofilm formed by human-derived nanoparticles, Nanomedicine, 10.2217/nnm.09.72, 4:8, (931-941), Online publication date: 1-Dec-2009. Jing J, Lu J, Hao Y and Han Y (2009) Nanobacteria's potential involvement in enamel repair in caries, Medical Hypotheses, 10.1016/j.mehy.2009.04.001, 73:3, (359-360), Online publication date: 1-Sep-2009. Demir T (2008) Is there any relation of nanobacteria with periodontal diseases?, Medical Hypotheses, 10.1016/j.mehy.2007.04.034, 70:1, (36-39), Online publication date: 1-Jan-2008. Miller N, Evan A and Lingeman J (2007) Pathogenesis of Renal Calculi, Urologic Clinics of North America, 10.1016/j.ucl.2007.05.007, 34:3, (295-313), Online publication date: 1-Aug-2007. Silay M and Miroglu C (2007) The risk of urolithiasis recurrence may be reduced with anti-nanobacterial therapy, Medical Hypotheses, 10.1016/j.mehy.2006.10.027, 68:6, (1348-1350), Online publication date: 1-Jan-2007. Hayden M, Tyagi S, Kolb L, Sowers J and Khanna R (2005) Vascular ossification – calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis – calcific uremic arteriolopathy: the emerging role of sodium thiosulfate, Cardiovascular Diabetology, 10.1186/1475-2840-4-4, 4:1, Online publication date: 1-Dec-2005. Puskás L, Tiszlavicz L, Rázga Z, Torday L, Krenács T and Papp J (2005) Detection of nanobacteria-like particles in human atherosclerotic plaques, Acta Biologica Hungarica, 10.1556/ABiol.56.2005.3-4.7, 56:3-4, (233-245), Online publication date: 1-Aug-2005. Maniscalco B and Taylor K (2004) Calcification in coronary artery disease can be reversed by EDTA–tetracycline long-term chemotherapy, Pathophysiology, 10.1016/j.pathophys.2004.06.001, 11:2, (95-101), Online publication date: 1-Oct-2004. August 26, 2003Vol 108, Issue 8 Advertisement Article InformationMetrics https://doi.org/10.1161/01.CIR.0000086781.16968.2DPMID: 12939248 Originally publishedAugust 26, 2003 PDF download Advertisement
Referência(s)